Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Current Leases: 2019-2024

Historic Current Leases for Bicycle Therapeutics (BCYC) over the last 6 years, with Dec 2024 value amounting to $5.3 million.

  • Bicycle Therapeutics' Current Leases rose 2.65% to $5.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $5.2 million, marking a year-over-year increase of 2.65%. This contributed to the annual value of $5.3 million for FY2024, which is 9.27% up from last year.
  • As of FY2024, Bicycle Therapeutics' Current Leases stood at $5.3 million, which was up 9.27% from $4.9 million recorded in FY2023.
  • In the past 5 years, Bicycle Therapeutics' Current Leases registered a high of $5.3 million during FY2024, and its lowest value of $844,000 during FY2020.
  • In the last 3 years, Bicycle Therapeutics' Current Leases had a median value of $4.9 million in 2023 and averaged $4.4 million.
  • Data for Bicycle Therapeutics' Current Leases shows a peak YoY surged of 182.35% (in 2021) over the last 5 years.
  • Yearly analysis of 5 years shows Bicycle Therapeutics' Current Leases stood at $844,000 in 2020, then soared by 182.35% to $2.4 million in 2021, then skyrocketed by 31.14% to $3.1 million in 2022, then skyrocketed by 56.03% to $4.9 million in 2023, then rose by 9.27% to $5.3 million in 2024.